Why the study?
Does moricizine effectively suppress ventricular arrhythmias compared to other class 1 antiarrhythmic agents?
Population
Patients with ventricular arrhythmias, including ventricular premature depolarizations, couplets…
Comparison
Moricizine vs Other class 1 antiarrhythmic agents
Design
Review
Authors
Loading...
May offer an alternative for ventricular arrhythmia suppression; leaves open need for randomized outcome trials.
Does moricizine effectively suppress ventricular arrhythmias compared to other class 1 antiarrhythmic agents?
Moricizine is a class 1 antiarrhythmic agent that offers comparable efficacy to existing agents for suppressing ventricular arrhythmias with a potentially favorable safety profile.
Carnes et al. (1990) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: